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Abstract 
If plans to modernise Europe’s healthcare infrastructure are to be sustained, new ways of 
financing it will have to be found. The PFI model has been seriously derailed by the 
recession, but new forms of public-private partnership – already being tried out in other 
European countries – may well offer more innovative approaches to delivering health 
services and infrastructure. 
Introduction 
Each year billions of euros are spent on upgrading or replacing ageing healthcare built 
infrastructure across Europe.1, 2 Major expenditure is needed, not only in the new member 
states – predominantly those with health systems inherited from the former Soviet era – but 
also in countries with a more modern estate such as Germany. And stimulus packages, 
assembled by European governments in response to the economic crisis, have to a degree 
targeted the upgrading of national infrastructure, including hospitals and other healthcare 
facilities.3  
But how will all this be paid for in an environment where finance and capital markets are 
blocked and public expenditure resources may be in increasingly short supply? As Nigel 
Edwards pointed out in a recent editorial in the JRSM, organisations with plans for capital 
expenditure are likely to find it hard to acquire funding in the current economic climate.4 
The current crisis 
Planning and delivering the infrastructure to meet future European healthcare needs has 
always challenged governments, healthcare providers, the finance sector and the 
construction industry. The complex relationships between long lasting fixed capital 
infrastructure, rapidly changing technologies and services, and a frequently unstable policy 
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context make for high levels of uncertainty about how and where capital investment should 
be directed. Combined with separate national health systems, tight government regulation, 
long maturities with low returns – and limited opportunities for income from mergers and 
acquisitions and corporate finance – this has conspired to ensure that the boardrooms of 
banks tend to be lukewarm about private investment in healthcare. The current credit crisis 
and economic recession have merely added another layer to these inherent complexities 
and uncertainties.  
The impact of the crisis on healthcare infrastructure investment 
Spending on European healthcare infrastructure is partly through direct public investment, 
partly through the European Union’s Structural Funds, and increasingly – in a number of 
countries – through private sector resources, in the form of various types of public-private 
partnership (PPP). However, with the economic crisis there has been a dramatic reduction in 
the number of third party investors available for healthcare infrastructure projects, and 
commercial banks are far less willing to invest.5  
TABLE 1. ABOUT HERE 
The impact of this has been especially evident in the UK Private Finance Initiative (PFI) 
market for hospital projects. Fewer projects were signed off over the last twelve months than 
during any other period over the last decade. The annual value of signed contracts for 
health-related PFI projects dwindled from a peak of over £3 billion in 2006 to £520 million in 
2008.6 Some of this is clearly due to the maturity of the PFI programme, with 53 schemes 
completed or on site in November 2008 out of a projected 78 over the lifetime of the 
programme.  However, of the remaining planned projects, the consensus is that the 
prospects are not good, largely due to the capital shortfall. Bailing these out is probably 
unsustainable and a leaked NHS memo warned that there was no ‘Plan B’ for maintaining 
the programme.7 Capital expenditure looks likely to enter a period of famine on both the 
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public sector and the commercial capital markets sides. The few projects going through in 
PFI are funded by a ‘club & hold’ model, where effectively a group of banks arranges the 
financing together in advance (previously, a lead bank would have developed a project then 
‘syndicated’ it to the banking market afterwards). This accesses the funding, but at the cost 
of reduced bank competition and therefore higher costs.   
So how does the picture look elsewhere? It is important to recognise that there is 
considerable diversity in the way the healthcare built infrastructure is provided throughout 
Europe, resulting from different histories, cultures and political trajectories. Across Europe 
the bulk of healthcare facilities are still paid for one way or another by the state or state-
controlled entities, either directly by grant or extracted from operating expenditures, for 
example via a component of diagnostic-related group payments (see table 1). In some 
countries with a social health insurance model, such as Germany, the public purse finances 
capital expenditure even if the sickness funds pay for recurrent cost.  All countries are facing 
the need for severe public expenditure restraint for the foreseeable future as governments 
repair massively-damaged balance sheets.8,9  For the medium term future – which may last 
some time if the gloomier projections of fiscal impact apply – governments will have to run 
significant primary surpluses in order to bring down the debt to sustainable levels. This 
means hard finance ministry choices. Typically, capital expenditure has been cut before 
recurrent expenditure because it is less job-intensive. Even when there may be benefits in 
the form of economic stimulus, new infrastructure projects will have to be ‘shovel-ready’ – 
signed off and ready to start – if they are to be seen as making a significant contribution. 
What of countries where there is already private provision? In Germany, there is a fast-
growing trend for private for-profit hospital companies to buy public or non-profit hospitals, 
but to operate them within the ‘Krankenhausplan’ state hospital framework, therefore without 
cream-skimming on choice of patients treated. In addition, voluntary health insurance has 
been making inroads in a number of countries in recent years. In most cases, private 
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hospitals are increasingly funded in equity and debt capital markets, like other corporations. 
The Netherlands will be an interesting laboratory in coming years, since the health sector 
has been reorganised into systems of competing insurance payers and hospital providers, 
with prices for services increasingly set by the marketplace. The predominance of not-for-
profit hospital trusts may be supplemented by for-profit hospital companies. 
Public-private partnerships vary in form and scope across Europe – some cover hospital 
accommodation, some hospital accommodation and clinical services, and others pick up 
elements of primary care too. The sustainability and appropriateness of these different 
models will need to be taken into account in designing future capital investment policies10, 
but in any event, the PPP markets in Continental Europe are no more capable of accessing 
large volumes of capital in the current economic climate than is the UK’s PFI.  
In short, choosing a private financing route for healthcare capital investment may be an 
attractive short term option for governments and healthcare providers, given the public 
expenditure squeeze. But liquidity is still a scarce resource – long term funding (> 5 years) is 
hard to get and expensive, competition is weak, only ‘good risks’ have access to funding, 
and healthcare has to compete with other industries. Already, those applying for private 
funding are not only experiencing shortages of finance, but have been confronted by far 
more rigid selection criteria by banks which, more than ever, are able to cherry-pick health 
infrastructure projects.  
The EU’s Structural Funds may offer a way out for some countries, especially the new 
member states with hospital facilities that are now unfit for purpose, but competition for these 
funds will rise and it is not clear that the health sector will get much more than its traditional 
1% share. 
The longer term 
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Once the immediate effects of the credit crisis have been washed out, the constraints on 
government budgets may actually increase both the motivation and opportunities for private 
healthcare investments. Prolonged economic downturn could provide financial investors with 
greater incentives to sign PPP-type contracts to secure long-term income from rising and 
relatively stable demand for health services. Private provision of healthcare infrastructure 
could be seen as a way of relieving the pressure on public systems. Banks may focus more 
on sustainable business and begin to see the formerly dull healthcare sector in a new light.11  
The pensions time bomb may provide an even sharper stimulus. Fundamentally, PPP and its 
variants are still an attractive market for governments as well as investing institutions, 
especially pension and insurance funds.  The fiscal burden of the current crisis to developed 
economies – only equalled in wartime – is in fact in net worth terms only about 11% of the 
ageing-related costs of pensions and healthcare in coming decades.9 But the exit path from 
the present crisis, extending as it does for years into the future, will make it even more 
difficult for governments to take on seamlessly their looming pension obligations, one much-
discussed wolf which is now approaching the door. Governments will have little choice but to 
endeavour to pass on much of their pension commitments to the private sector, which will 
then have to create assets to match the liabilities. Healthcare capital investment, providing a 
relatively stable if not high return, could well be part of the mix of these assets – and with the 
neat effect of being to some degree correlated with the services being demanded.  
Future models for public private partnerships? 
What might future models of PPP look like in the UK? Although PFI has been controversial 
and divisive, there are some fundamental reasons why this approach was an attractive 
instrument for delivering new healthcare infrastructure since it allows governments to offset 
the risk of and responsibility for development to private parties. Concerns have largely 
revolved around a perceived lack of value for money12,13The current funding difficulties have 
brought to a head the desirability of a rethink on more fundamental grounds, moving the 
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model away from infrastructure -only projects. One of the most cogent reservations about 
UK-style PFI for hospitals is that the incentives and risks allocated between the different 
parties – those controlling the services and those controlling the estate – are not properly 
aligned, and arguably the result is long-term inflexibility of the facilities.14 
Future PFI projects may separate the construction of the infrastructure from facilities 
management, with the latter being subject to more frequent re-competition and in-house 
provision where this ensures value for money. Other possibilities would be to extend the PFI 
project beyond accommodation, and there are other models for this in Europe.1 The 
Portuguese Ministry of Health has been letting contracts for hospital PPPs with separate but 
overlapping infrastructure and clinical service special purpose companies, although it is now 
turning back to a more conventional model. And the Hospital de la Ribera at Alzira in 
Valencia is a PPP with a whole-population responsibility for both primary and secondary 
care for its region, and payment by capitation. The project started as a relatively 
conventional accommodation PPP, albeit with population capitation providing the payment 
stream rather than, say, the availability and performance charges used in the UK. However, 
after some difficulties the project was reorganised to give the company responsibility for 
community services as well, with an expanded capitation payment, but freedom for citizens 
to go elsewhere (and any costs so incurred being absorbed by the company). This provides 
an incentive for the project company to treat the patient in the most cost-effective setting, not 
just in the hospital. The jury is out as to whether such alternative models will offer sound 
long-term contractual structures, but perhaps it is time to examine whether UK PFI stacks up 
well against these and other alternatives. 
In the long term the current economic crisis may also reinforce moves towards the redesign 
of healthcare services, with a knock-on impact on infrastructure. Significant efficiency 
savings need to be achieved in the UK and elsewhere, such as reducing waste, eliminating 
rework and making sure that patients follow the most efficient pathways, inside and outside 
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of the hospital.4 Rethinking the role of expensive healthcare facilities is also needed. 
‘Hospitals’ are often remarkably resistant to change, but in the longer run problems in paying 
for expensive facilities may well stimulate moves to shift care into wider community settings 
through the use of innovations such as telecare, as well as to scale down the size of built 
assets. 
Conclusions 
The need for modern healthcare infrastructure will outlast any short term impact of recession 
on the population’s health and wellbeing. How to pay for this, in the course of a trajectory 
towards large ageing-related healthcare and pension commitments, is a major challenge for 
governments and health services across Europe. The economic crisis, and need for 
governments in countries where healthcare infrastructure is essentially publicly funded to 
reign in expenditure, may reinforce moves already underway towards an increased role for 
the private sector. In the short run, public-private partnerships in other European countries 
will face exactly the same difficulties as those in the UK – little or no available funding. But 
the longer run outlook for countries seeking to increase the role of the private sector in 
capital funding for healthcare projects may be less bleak. Banks may eventually see 
healthcare in a new light, as a form of stable and safe – albeit not high-return – investment, 
driving new and innovative forms of public-private partnership. 
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TABLE 1. SUMMARY OF CURRENT CAPITAL FUNDING APPROACHES IN SELECTED EUROPEAN COUNTRIES 
Country Predominant 
healthcare finance 
source 
Role of private capital in infrastructure and services provision 
Finland Tax Limited accommodation & clinical PPP 
France SHI* Big private elective sector 
Some accommodation PPP 
Germany SHI* Rapid growth in for-profit provision under state concession 
Mostly state grants for capital expenditure  
PPP experiments 
Italy Tax Small private sector 
Limited accommodation PPP 
Netherlands SHI* Not-for-profit trusts 
Most hospitals use bank debt 
Future competition between hospitals & insurance companies will determine capital 
source 
Portugal Tax Accommodation & clinical PPPs 
Now accommodation PPP 
Spain Tax Accommodation PPP & some accommodation ‘public-public partnership’ 
Sweden Tax PPP possible 
UK Tax Small private elective sector 
Massive accommodation PPP development (PFI) 
Independent diagnostic & treatment centres 
* SHI – social health insurance 
 
